The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
Abstract
This paper describes the AACTG Adherence Instruments, which are comprised of two self-report questionnaires for use in clinical trials conducted by the Adult AIDS Clinical Trials Group (AACTG). The questionnaires were administered to 75 patients at ten AACTG sites in the USA. All patients were taking combination antiretroviral therapy (ART), including at least one protease inhibitor. Eleven per cent of patients reported missing at least one dose the day before the interview, and 17% reported missing at least one dose during the two days prior. The most common reasons for missing medications included 'simply forgot' (66%) and a number of factors often associated with improved health, including being busy (53%), away from home (57%) and changes in routine (51%). Less adherent patients reported lower adherence self-efficacy (p = 0.006) and were less sure of the link between non-adherence and the development of drug resistance (p = 0.009). They were also more likely to consume alcohol, to be employed outside the home for pay and to have enrolled in clinical trials to gain access to drugs (all p < 0.05). Twenty-two per cent of patients taking drugs requiring special instructions were unaware of these instructions. Each questionnaire took approximately ten minutes to complete. Responses to the questionnaires were favourable. These questionnaires have been included in six AACTG clinical trials to date and have been widely disseminated to investigators both in the USA and abroad.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The VIRAHEP-C self-efficacy measure was a 24-item self-report measure adapted from previously validated self-efficacy measures created for the Adult AIDS Clinical Trials Group (see Appendix A for the original VIRAHEP-C measure) (19;39) (personal communication, S. Smith, Nov. 11, 2010).”
From Reliability and validity of a self‐efficacy instrument for hepatitis C antiviral treatment regimens (2012) · cites this paper as [39]
Citations
Cites
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Hesselbart, S., & Fowler, F. J. (1985) · Journal of the American Statistical Association · doi:10.2307/2288598 · Cited by 4,767
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,627
Mirowsky, J., & Ross, C. E. (1992) · Journal of Health and Social Behavior · doi:10.2307/2137349 · Cited by 856
Hecht, F. M., Grant, R. M., Petropoulos, C. J., Dillon, B. A., Chesney, M. A., Tian, H., Hellmann, N. S., Bandrapalli, N. I., Digilio, L., Branson, B. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390504 · Cited by 443
Self-citationPatient Compliance and Drug Failure in Protease Inhibitor Monotherapy
Vanhove, G. F. (1996) · JAMA · doi:10.1001/jama.1996.03540240033024 · Cited by 193
Protease Inhibitors in the Homeless
Bangsberg, D. R. (1997) · JAMA · doi:10.1001/jama.1997.03550010077044 · Cited by 150
Besch, C. L. (1995) · AIDS · doi:10.1097/00002030-199501000-00001 · Cited by 148
Predictors of patient adherence: Patient characteristics.
Dunbar, J. (1990) · Cited by 83
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Can you hear me now? Limited use of technology among an urban HIV-infected cohort
Shacham, E., Stamm, K., & Overton, E. T. (2009) · AIDS Care · doi:10.1080/09540120802612832 · Cited by 16
“The validated four-day AIDS Clinical Trial Group (ACTG) measure of selfreported medication adherence was used (Chesney et al., 2000).”
MethodMaru, D., Kozal, M. J., Bruce, R. D., Springer, S. A., & Altice, F. L. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318158c0bd · Cited by 16
Algorithm for assessing patients’ adherence to oral hypoglycemic medication
Kilbourne, A. M., Good, C. B., Sereika, S. M., Justice, A. C., & Fine, M. J. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.2.198 · Cited by 16
Aibibula, W., Cox, J., Hamelin, A., Moodie, E., Naimi, A., McLinden, T., Klein, M. B., & Brassard, P. (2017) · HIV Medicine · doi:10.1111/hiv.12561 · Cited by 15
Yu, B., Jia, P., Huang, Y., Zhou, J., Xie, T., Yu, J., Liu, C., Xiong, J., Han, J., Yang, S., et al. (2021) · AIDS Care · doi:10.1080/09540121.2021.1938964 · Cited by 15
“Referring to the AIDS Clinical Trials Group Adherence Questionnaire (ACTG) (Chesney et al., 2000) and related literature (Safren et al., 2015), we adopted two time points to measure medication adherence.”
MethodTrepka, M. J., Ward‐Peterson, M., Fennie, K., Sheehan, D. M., Fernandez, S. B., Li, T., Jean-Gilles, M. M., Dévieux, J. G., Ibañez, G. E., Gwanzura, T., et al. (2023) · AIDS Patient Care and STDs · doi:10.1089/apc.2023.0029 · Cited by 15
Mutual Role of Patients and the Healthcare System in the Control of Cutaneous Leishmaniasis
Bamorovat, M., Sharifi, I., Afshari, S. A. K., & Almani, P. G. N. (2023) · Transboundary and Emerging Diseases · doi:10.1155/2023/7814940 · Cited by 15
“Anxiety, depression, and how people manage their stress are the main important determinants of treat-ment obedience [79 – 81].”
Taiwo, B., Acosta, E. P., Ryscavage, P., Berzins, B., Lu, D., Lalezari, J. P., Castro, J. G., Adeyemi, O. M., Kuritzkes, D. R., Eron, J. J., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182a03d95 · Cited by 15
Chabikuli, N., Datonye, D., Nachega, J. B., & Ansong, D. (2010) · South African Family Practice · doi:10.1080/20786204.2010.10874005 · Cited by 15
Cuong, D. D., Sönnerborg, A. B., Tam, V. V., El‐Khatib, Z., Santacatterina, M., Marrone, G., Chúc, N. T. K., Diwan, V. K., Thorson, A. E., Le, N. K., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-2017-x · Cited by 15
Laher, A. E., Richards, G. A., Paruk, F., & Venter, F. (2021) · South African Medical Journal · doi:10.7196/samj.2021.v111i8.15604 · Cited by 15
“The four-question AIDS Clinical Trials Group Adherence Questionnaire (ACTG-AQ) was utilised to determine non-adherence to ART: (i) have you missed your antiretroviral therapy pills yesterday; (ii) have you missed your antiretroviral therapy pills the day before yesterday; (iii) have you missed your antiretroviral ther…”
MethodSibinga, E. M. S., Webb, L., Perin, J., Tepper, V. J., Kerrigan, D. L., Grieb, S. M. D., Denison, J. A., & Ellen, J. M. (2022) · AIDS Care · doi:10.1080/09540121.2022.2105796 · Cited by 15
“The primary outcome was HIV medication adherence (MA), measured by a 15-question self-report questionnaire (Chesney et al., 2000), assessing number of pills prescribed and taken/week, missed doses in past week, and barriers to taking medication.”
MethodNewville, H., Berg, K. M., & Gonzalez, J. S. (2014) · International Journal of Behavioral Medicine · doi:10.1007/s12529-014-9429-z · Cited by 15
Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence
Nahvi, S., Litwin, A. H., Heo, M., Berg, K. M., Li, X., & Arnsten, J. H. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.07.025 · Cited by 15
“Baseline antiretroviral adherence was assessed via selfreport, and dichotomized at 100%, as has been done previously (Chesney et al., 2000; Simoni et al., 2006).”
Edén, A., Andersson, L., Andersson, Ö., Flamholc, L., Josephson, F., Nilsson, S., Ormaasen, V., Svedhem, V., Säll, C., Sönnerborg, A. B., et al. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2009.0177 · Cited by 15
Abgrall, S., Fugon, L., Lele, N., Carde, E., Bentata, M., Patey, O., Khuong, M.-A., Spire, B., Carrieri, P., & Bouchaud, O. (2013) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325957413488181 · Cited by 15
“Overall, the median (interquartile range [IQR]) planned duration of time spent abroad was 5 weeks (4-9) and the median (IQR) actual duration was 6 (4-9), with 4 participants staying for more than 6 months (11, 14, 15, and 24 months).”
BackgroundHAART Adherence Strategies for Methadone Clients Who Are HIV-Positive
Haug, N. A., Sorensen, J. L., Gruber, V. A., Lollo, N., & Roth, G. S. (2006) · Behavior Modification · doi:10.1177/0145445506288229 · Cited by 15
“Next, Audio-CASI assesses patients’ adherence during the previous 3-day period, using the Adult AIDS Clinical Trials Group (AACTG) self-reported adherence questions (Chesney et al., 2000).”
MethodDevelopment and evaluation of the Measure of Drug Self-Management
Bailey, S. C., Annis, I. E., Reuland, D. S., Locklear, A., Sleath, B. L., & Wolf, M. S. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s85411 · Cited by 15
L’observance dans la maladie de Wilson : intérêt d’un suivi rapproché au long cours
Jacquelet, E., Beretti, J., Tassigny, A. D., Girardot, N., Wenisch, É., Lachaux, A., Pheulpin, M., Poujois, A., & Woimant, F. (2017) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2017.11.010 · Cited by 15
Antiretroviral Adherence Trajectories Among Black Americans Living with HIV
Storholm, E. D., Bogart, L., Mutchler, M. G., Klein, D. J., Ghosh-Dastidar, B., McDavitt, B., & Wagner, G. (2018) · Aids and Behavior · doi:10.1007/s10461-018-2303-2 · Cited by 18
Assessing Medication Adherence of Perinatally HIV-Infected Children Using Caregiver Interviews
Allison, S. M., Koenig, L. J., Marhefka, S. L., Carter, R. J., Abrams, E. J., Bulterys, M., Tepper, V. J., Palumbo, P. E., Bachanas, P. J., & Farley, J. J. (2010) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2010.02.006 · Cited by 15
“Although the focus in the pub- lished data has been on the assessment of adherence for recent doses to minimize bias and maximize recall (Chesney et al., 2000), these findings suggest that only including questions regarding recent missed doses will result in limited information about the child’s…”
ResultPromoting Health and Well-being in Lives of People Living with HIV and AIDS
Biswas, U. N. (2007) · Psychology and Developing Societies · doi:10.1177/097133360701900205 · Cited by 15
Higgins, N. M., Zingman, B. S., Slish, J. C., Reichman, R. C., Fischl, M. A., Gripshover, B., Tooley, K. M., Boston, N., Forrest, A., Brazeau, D. A., et al. (2007) · American Journal on Addictions · doi:10.1080/10550490701641256 · Cited by 15
Measures of antiretroviral adherence for detecting viral non-suppression in people living with HIV
Hine, P., Smith, R., Eshun‐Wilson, I., Orrell, C., Cohen, K., Leeflang, M., & Ford, N. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013080 · Cited by 14
Andersson, L., Vesterbacka, J., Blaxhult, A., Flamholc, L., Nilsson, S., Ormaasen, V., Sönnerborg, A. B., & Gisslén, M. (2013) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2012.756985 · Cited by 14
Pokhrel, K. N., Pokhrel, K. G., Sharma, V. D., Poudel, K. C., Neupane, S. R., Mlunde, L. B., & Jimba, M. (2019) · AIDS Care · doi:10.1080/09540121.2019.1587365 · Cited by 14
“Non-adherence to ART and the reasons for it were assessed using the questionnaires developed by the adult AIDS clinical trial group (Chesney et al., 2000).”
MethodKarway, G. K., Grando, A., Grimm, K. J., Groat, D., Cook, C. B., & Thompson, B. (2020) · Applied Clinical Informatics · doi:10.1055/s-0039-1701002 · Cited by 13
Schensul, S. L., Ha, T., Schensul, J. J., Grady, J. J., Burleson, J. A., Gaikwad, S., Joshi, K., Malye, R., & Sarna, A. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03303-y · Cited by 14
“ART adherence for first line medication, primarily Tenofovir disoproxil fumarate + Lamivudine + Efavirenz (TLE), measured with the AIDS Clinical Trials Group (ACTG) instrument [40], elicited recall responses on the number of missed doses for each prescribed medication during the 4 days prior to the administration of t…”
MethodWanyenze, R. K., Matovu, J. K. B., Bouskill, K., Juncker, M., Namisango, E., Nakami, S., Beyeza‐Kashesya, J., Luyirika, E. B. K., & Wagner, G. J. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-01211-z · Cited by 14
Combined effects of loneliness and inflammation on depression in people with HIV
Hussain, M., Watson, C. W., Morgan, E. E., Heaton, R. K., Letendre, S. L., Jeste, D. V., Moore, D. J., & Iudicello, J. E. (2023) · Journal of NeuroVirology · doi:10.1007/s13365-023-01145-z · Cited by 15
“…to gather a comprehensive medical history (e.g., medical conditions, medications, etc.) as well as a blood draw, breathalyzer and urine drug screen, and self-report questionnaires (e.g., AIDS Clinical Trials Group [ACTG] Adherence Questionnaire [4-day adherence of > 90%]; Chesney et al. 2000).”
BackgroundAdherence-Related Issues in Adolescents and Young Adults with Hematological Disorders
Leader, A., & Raanani, P. (2014) · Acta Haematologica · doi:10.1159/000360197 · Cited by 15
HIV and tuberculosis in Durban, South Africa: adherence to two medication regimens
Corless, I. B., Wantland, D. J., Bhengu, B., McInerney, P. A., Ncama, B. P., Nicholas, P. K., McGibbon, C. A., Wong, E. B., & Davis, S. (2009) · AIDS Care · doi:10.1080/09540120902729932 · Cited by 14
Crane, H. M., Nance, R. M., Merrill, J. O., Hutton, H. E., Chander, G., McCaul, M. E., Mathews, W. C., Fredericksen, R. J., Simoni, J. M., Mayer, K. H., et al. (2016) · AIDS Care · doi:10.1080/09540121.2016.1204418 · Cited by 14
“…is measured by a 30-day visual analog scale item (VAS) (Amico et al., 2006), a 30-day self-rating item (Feldman et al., 2012; Lu et al., 2008), and by items from the Adult AIDS Clinical Trial Group (AACTG) adherence measure, including an item on time since last missed dose (Chesney et al., 2000).”
MethodSauceda, J. A., Neilands, T. B., Johnson, M. O., & Saberi, P. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1759-9 · Cited by 14
“, barriers) for missing a dose of ART [15].”
BackgroundBezabih, T., Weiser, S. D., Menbere, M.-S., Negash, A., & Grede, N. (2017) · AIDS Care · doi:10.1080/09540121.2017.1371667 · Cited by 14
“(AACTG) adherence baseline questionnaire developed by the AIDS Clinical Trials Group (ACTG) Recruitment, Adherence and Retention Subcommittee (Chesney et al., 2000).”
MethodNegi, B. S., Joshi, S. K., Nakazawa, M., Kotaki, T., Bastola, A., & Kameoka, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198071 · Cited by 15
Jiang, M., Yang, J., Song, Y., Zheng, J., Li, X., Yang, G., Ma, Y., Xu, P., Zhang, Z., Pan, X., et al. (2019) · AIDS Care · doi:10.1080/09540121.2019.1587360 · Cited by 15
Laher, A. E., Paruk, F., Venter, W., Ayeni, O., & Richards, G. A. (2021) · HIV Medicine · doi:10.1111/hiv.13097 · Cited by 14
Preventing Medication Errors in Ambulatory Care: The Importance of Establishing Regimen Concordance
Schillinger, D., Machtinger, E., Wang, F. M., Rodriguez, M., & Bindman, A. B. (2007) · Journal of Medical Regulation · doi:10.30770/2572-1852-93.3.20 · Cited by 14
Childers, M. E., Woods, S. P., Letendre, S. L., McCutchan, J. A., Rosario, D., Grant, I., Mindt, M. R., Ellis, R. J., & R, T. S. D. H. N. (2008) · Journal of NeuroVirology · doi:10.1080/13550280802372313 · Cited by 14
“Adherence to antiretroviral medications was assessed in 10 of 11 subjects using the AIDS Clinical Trials Group’s brief self-report instrument (Chesney et al, 2000).”
Aportaciones desde la Psicológía al tratamiento de las personas con infección por VIH/SIDA
Ballester‐Arnal, R. (2005) · Revista de Psicopatología y Psicología Clínica · doi:10.5944/rppc.vol.10.num.1.2005.3989 · Cited by 14
Psychological distress, substance use, and adjustment among parents living with HIV.
Goldstein, R., Johnson, M. O., Rotheram-Borus, M., Kirshenbaum, S., Pinto, R. M., Kittel, L., Pequegnat, W., Mickalian, J. D., Weinhardt, L., Kelly, J., et al. (2005) · The Journal of the American Board of Family Practice · doi:10.3122/jabfm.18.5.362 · Cited by 18
Pulerwitz, J., Gottert, A., Tun, W., Eromhonsele, A. F., Oladimeji, P. L., Shoyemi, E., Akoro, M., Ndeloa, C., & Adedimeji, A. (2024) · Journal of the International AIDS Society · doi:10.1002/jia2.26256 · Cited by 15
Pellowski, J. A., Kalichman, S. C., & Finitsis, D. J. (2015) · HIV Clinical Trials · doi:10.1179/1528433614z.0000000004 · Cited by 13
Weiss, S. M., Tobin, J. N., Lopez, M., Simons, H. R., Cook, R., & Jones, D. L. (2014) · International Journal of Behavioral Medicine · doi:10.1007/s12529-014-9399-1 · Cited by 13
Gnatienko, N., Han, S. C., Krupitsky, E. M., Blokhina, E. A., Bridden, C. L., Chaisson, C. E., Cheng, D. M., Walley, A. Y., Raj, A., & Samet, J. H. (2016) · Addiction Science & Clinical Practice · doi:10.1186/s13722-016-0058-5 · Cited by 13
Almeida-Brasil, C. C., Moodie, E. E. M., McLinden, T., Hamelin, A.-M., Walmsley, S. L., Rourke, S. B., Wong, A., Klein, M. B., & Cox, J. (2018) · AIDS · doi:10.1097/qad.0000000000001822 · Cited by 13
An E-Learning Program Improves Patients' Knowledge After Lung Transplantation
Guldager, T. B., Hyldgaard, C., Hilberg, O., & Bendstrup, E. M. (2020) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2020.0101 · Cited by 13
“Adherence to medication intake was assessed using the Basel Assessment of Adherence with Immunosuppressive Medication Scale (BAASIS) and the Transplant Adherence Questionnaire (TAQ), 3,10,23 which were completed by all participants.”
Laher, A. E., Venter, F., Richards, G. A., & Paruk, F. (2021) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v22i1.1177 · Cited by 13
Cook, P. F., Jankowski, C. M., Erlandson, K. M., Reeder, B., Starr, W., & Makic, M. B. F. (2022) · JMIR mhealth and uhealth · doi:10.2196/33938 · Cited by 13
Patel, S. N., Weiss, E. S., Chhabra, R., Ryniker, L., Adsuar, R., Carness, J., Kahalas, W., DeLaMarter, C., Feldman, I. S., DeLorenzo, J., et al. (2008) · AIDS Patient Care and STDs · doi:10.1089/apc.2007.0105 · Cited by 13
In-Home Mental Health Treatment for Individuals with HIV
Reif, S., Pence, B. W., LeGrand, S., Wilson, E., Swartz, M. S., Ellington, T., & Whetten, K. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0242 · Cited by 13
Brouwer, E., Napravnik, S., Smiley, S. G., Corbett, A., & Eron, J. J. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2096 · Cited by 13
Vitalis, D. (2017) · International Journal of STD and AIDS · doi:10.1177/0956462416665989 · Cited by 13
Power, J., Brown, G., Lyons, A., Thorpe, R. D., Dowsett, G. W., & Lucke, J. C. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00050 · Cited by 14
Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study
Saberi, P., Ming, K., Legnitto, D., Neilands, T. B., Gandhi, M., & Johnson, M. O. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s166380 · Cited by 13
Ramlagan, S., Rodriguez, V. J., Peltzer, K., Ruiter, R. A. C., Jones, D. L., & Sifunda, S. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02563-z · Cited by 13
Ojo-Fati, O., Thomas, J. L., Vogel, R. I., Ogedegbe, O., Jean‐Louis, G., & Okuyemi, K. S. (2016) · PubMed · Cited by 13
Factors affecting adherence and convenience in antiretroviral therapy
Lafeuillade, A. (2001) · International Journal of STD & AIDS · doi:10.1258/0956462011924290 · Cited by 13
ART adherence in resource poor settings in sub-Saharan Africa: a multidisciplinary review
Wekesa, E. (2017) · Cited by 13
Valderrama, E. T., Ortiz, C., Alfaro, C. O., García‐Jiménez, E., & Faus, M. J. (2008) · Institutional Repository of the University of Granada (University of Granada) · doi:10.30827/ars.v49i3.4967 · Cited by 13
McIntosh, R. C., Ironson, G. H., Antoni, M. H., FLETCHER, M. A., & Schneiderman, N. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1126-7 · Cited by 13
“Prescribed medications and adherence were assessed through an interviewer-administered AIDS Clinical Trials Group (ACTG) Adherence Measure [82].”
BackgroundMethodHarrison, A., Scott, W., Timmins, L., Graham, C. D., & Harrison, A. M. (2021) · AIDS Care · doi:10.1080/09540121.2020.1771263 · Cited by 12
“Using an adherence measure validated in PLWHIV with established cut-offs and a specific timeframe may help (e.g., (Chesney et al., 2000).”
MethodHIV-specific unsupportive social interactions, health, and ethnicity in men living with HIV
Fekete, E. M., Deichert, N. T., & Williams, S. L. (2013) · Journal of Social and Personal Relationships · doi:10.1177/0265407513506796 · Cited by 12
“The General Health Behaviors measure developed by the Adult AIDS Clinical Trials Group (AACTG) was used as a guide in creating this measure (Chesney et al., 2000).”
MethodRodkjær, L. Ø., Storgaard, M., Sørensen, N. T., & Schougaard, L. M. V. (2023) · AIDS Research and Therapy · doi:10.1186/s12981-023-00562-8 · Cited by 12
“Adherence was assessed by asking about missed doses over the preceding four days: “During the past four days, on how many days have you missed taking all your doses?” with the following response categories: “none”, “one day”, “two days”, “three days”, “four days” [18].”
MethodSoeters, H. M., Napravnik, S., Zakharova, O. I., Eron, J. J., & Hurt, C. B. (2013) · AIDS · doi:10.1097/01.aids.0000433240.78739.30 · Cited by 12
“Unautho records, UCHCC participants were offered the opportunity to complete a comprehensive, standardized, face-to-face interview, the Clinical, Sociodemographic and Behavioral Survey (CSDS), which incorporates multiple validated instruments, including 4-day adherence recall [36] and alcohol and substance use assessm…”
MethodCallon, W. A., Saha, S., Korthuis, P. T., Wilson, I. B., Moore, R. D., Cohn, J. A., & Beach, M. C. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1231-7 · Cited by 12
Clinical and Economic Implications of Non-Adherence to HAART in HIV Infection
Scalera, A., Bayoumi, A. M., OH, P. I., Risebrough, N. A., Shear, N. H., & Tseng, A. L.-I. (2002) · Disease Management & Health Outcomes · doi:10.2165/00115677-200210020-00003 · Cited by 12
Begley, K., McLaws, M., Ross, M. W., & Gold, J. (2008) · Clinical Psychologist · doi:10.1080/13284200802069043 · Cited by 12
“, 2002), conviction about connection between non-adherence and resistance (Chesney et al., 2000), treatment motivation (Duong et al.”
BackgroundMethodInfluentialRobbins, G. K., Cohn, S. E., Harrison, L. J., Smeaton, L. M., Moran, L. E., Rusin, D., Dehlinger, M., Flynn, T., Lammert, S. M., Wu, A. W., et al. (2016) · HIV Clinical Trials · doi:10.1080/15284336.2016.1189754 · Cited by 12
Self-citationSchensul, J. J., Ha, T., Schensul, S. L., Sarna, A., & BRYANT, K. J. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1916-1 · Cited by 12
“From the Baseline survey three self-reported adherence measures were used: an Adult AIDS Clinical Trials Group (AACTG) 4-days recall adherence instrument [57], and a single question asking about number of days of missed doses in past 7 days.”
MethodKim, H., Dowdy, D. W., Martinson, N. A., Kerrigan, D. L., Tudor, C., Golub, J. E., Bridges, J. F. P., & Hanrahan, C. F. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2324-x · Cited by 12
Tailoring Cognitive Behavioral Therapy for Trauma-Exposed Persons Living With HIV
López, C. M., Hahn, C. K., Gilmore, A. K., & Danielson, C. K. (2019) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2019.02.006 · Cited by 12
“The AIDS Clinical Trial Group (ACTG) Adherence Questionnaire (Chesney et al., 2000; Reynolds et al., 2007) is a validated adherence instrument with varying recall periods for past 4 days, past 3 days, past 2 days, past week, or past month.”
MethodYang, X., Wang, Z. J., Harrison, S. E., & Lau, J. T. F. (2019) · Tropical Medicine & International Health · doi:10.1111/tmi.13353 · Cited by 12
Cunningham, C. O., Starrels, J. L., Zhang, C., Bachhuber, M. A., Sohler, N., LEVIN, F. R., Minami, H., Slawek, D. E., & Arnsten, J. H. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-043400 · Cited by 12
Zewude, S. B., & Ajebe, T. M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056009 · Cited by 12
Depression and Its Relationship to Work Status and Income among HIV Clients in Uganda
Wagner, G. J., Ghosh‐Dastidar, B., Akena, D. H., Nakasujja, N., Okello, E. S., Luyirika, E. B. K., & Musisi, S. (2012) · World Journal of AIDS · doi:10.4236/wja.2012.23018 · Cited by 12
“adapted from the ACTG assessment battery [25], “I can count on my family and friends to give me the support I need”, and a 4-point rating scale from 1 “strongly dis-”
Ballester, R., García, S., Reinoso, I., & Campos, A. (2002) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 12
Aurpibul, L., Detsakunathiwatchara, C., Khampun, R., Wongnum, N., Chotecharoentanan, T., & Sudjaritruk, T. (2022) · AIDS Care · doi:10.1080/09540121.2022.2075537 · Cited by 11
“The role of adherence self-efficacy in treatment adherence has been documented in previous studies (Chesney et al., 2000).”
ResultShuper, P. A., Joharchi, N., & Rehm, J. T. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1128-5 · Cited by 11
“Two validated scales are employed to assess adherence, which include (1) a visual analogue scale (VAS) to identify the percentage of ART doses taken over the past month [64], and (2) an ACTGbased assessment that queries the number of doses of each ART medication missed over the past 4 days [65].”
Seay, J., Lattie, E. G., Schneiderman, N., Antoni, M. H., Fekete, E. M., Mendez, A. J., Szeto, A., & FLETCHER, M. A. (2014) · Journal of Applied Biobehavioral Research · doi:10.1111/jabr.12016 · Cited by 13
Tatum, A. K., & Houston, E. (2016) · AIDS Care · doi:10.1080/09540121.2016.1220481 · Cited by 11
“Self-reported adherence was assessed with the AIDS Clinical Trials Group adherence questionnaire (Chesney et al., 2000).”
MethodJiang, Y., Li, X., Cho, H., Brown, M. J., Qiao, S., & Haider, M. R. (2019) · Journal of Health Psychology · doi:10.1177/1359105319869809 · Cited by 11
“ART adherence was measured using three items adapted from the Adult AIDS Clinical Trials Group adherence instrument (Chesney et al., 2000), with a focus on recent adherence to reduce recall bias.”
MethodBenoit, A. C., Burchell, A. N., O’Brien, K. K., Raboud, J., Gardner, S. L., Light, L., Beaver, K., Cotnam, J., Conway, T., Price, C. E., et al. (2020) · HIV Research & Clinical Practice · doi:10.1080/25787489.2020.1763711 · Cited by 9
Personality and adherence to antiretroviral therapy in HIV-infected adult patients
Hernández-Huerta, D., Parro-Torres, C., Madoz‐Gúrpide, A., Pérez-Elı́as, M. J., Moreno, S., & Mangado, E. O. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110413 · Cited by 11
Quality of Life and Antiretroviral Therapy Adherence: A Cross-Sectional Study in Colombia
Narváez, M., Lins-Kusterer, L., Valdelamar-Jiménez, J. R., & Brites, C. R. (2022) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2021.0233 · Cited by 11
“28 Adherence was calculated as the number of doses taken divided by the number of doses prescribed in the last 4 days.”
Rivero‐Méndez, M., Suárez-Pérez, E. L., & Solís-Báez, S. S. (2015) · PubMed · Cited by 11
Protopopescu, C., Raff, F., Spire, B., Hardel, L., Michelet, C., Cheneau, C., Moing, V. L., Leport, C., Carrieri, P., & the ANRS CO8 APROCO-COPILOTE Study Group (2014) · Antiviral Therapy · doi:10.3851/imp2960 · Cited by 11
Feaster, D. J., Reznick, O. G., Zack, B., McCartney, K., Gregorich, S. E., & Brincks, A. M. (2013) · Journal of Correctional Health Care · doi:10.1177/1078345813499312 · Cited by 11
Houston, E., & Fominaya, A. W. (2014) · Psychology Health & Medicine · doi:10.1080/13548506.2014.986137 · Cited by 11
“Self-reported adherence was assessed with the AIDS Clinical Trials Group adherence questionnaire (Chesney et al., 2000).”
MethodCrane, H. M., Nance, R. M., Delaney, J. A., Fredericksen, R. J., Church, A. E., Simoni, J. M., Harrington, R. D., Dhanireddy, S., Safren, S. A., McCaul, M. E., et al. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1566-8 · Cited by 11
“These more complex recall items such as sometimes used in the early ACTG studies [37] are more time-consuming and confusing and are thus of limited feasibility for wide-spread use in routine clinical care where regimens vary.”
Depression Among Alcohol Consuming, HIV Positive Men on ART Treatment in India
Ha, T., Schensul, S. L., Irving, M. L., Brault, M. A., Schensul, J. J., Prabhughate, P., & Vaz, M. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2339-3 · Cited by 11
Bruck-Segal, D., Schwartz, R. M., Cohen, M. H., Weber, K. M., Burke-Miller, J. K., Kassaye, S., & Brody, L. R. (2019) · Sex Roles · doi:10.1007/s11199-019-01086-0 · Cited by 12
Tindle, H. A., Freiberg, M. S., Gnatienko, N., Blokhina, E. A., Cheng, D. M., Yaroslavtseva, T. V., Bendiks, S., Winter, M. R., Krupitsky, E. M., & Samet, J. H. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100625 · Cited by 11
Tanner, A. E., Dowshen, N., Philbin, M. M., Rulison, K. L., Camacho-González, A., Lee, S., Moore, S. J., Fortenberry, J. D., & Hussen, S. A. (2021) · JMIR Research Protocols · doi:10.2196/24565 · Cited by 12
Ogbonnaya, I. N., Reed, E., Wanyenze, R. K., Wagman, J. A., Silverman, J. G., & Kiene, S. M. (2021) · Journal of Interpersonal Violence · doi:10.1177/08862605211028284 · Cited by 11
Adhesión terapéutica : revisión histórica y estado de la cuestión en la infección por VIH/SIDA
Ballester, R. (2013) · Revista de Psicopatología y Psicología Clínica · doi:10.5944/rppc.vol.7.num.3.2002.3931 · Cited by 11
“(2000) Moatti et al. (2000) Olvido Hecht (1997) Chesney et al. (2000) Adhesión terapéutica en la infección por VIH/SIDA 165 tran el nivel educativo, las creencias culturales del paciente, la valoración de la gravedad de la enfermedad, la percepción acerca de la eficacia del tratamiento, la…”
BackgroundThe Challenge of HIV for Feminist Theory
Rosengarten, M. (2004) · Feminist Theory · doi:10.1177/1464700104045409 · Cited by 11
“Yet taking pills is now well-documented within HIV social and psycho-social literature to be difficult for many and for a variety of reasons (Chesney et al., 2000; Race and Wakeford, 2000).”
BackgroundSocial Networks of Substance Users With HIV Infection
Kelly, P. J., Ramaswamy, M., Li, X., Litwin, A. H., Berg, K. M., & Arnsten, J. H. (2011) · Western Journal of Nursing Research · doi:10.1177/0193945911419679 · Cited by 11
“This instrument was developed for use by the Adult AIDS Clinical Trials Group and has been widely used both domestically and internationally (Chesney et al., 2000).”
MethodResultFood insecurity, HIV disease progression and access to care among HIV-infected Russians not on ART
Idrisov, B., Lunze, K., Cheng, D. M., Blokhina, E., Gnatienko, N., Patts, G. J., Bridden, C., Kleinman, R. E., Weiser, S. D., Krupitsky, E., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1885-4 · Cited by 9
“The date of ART initiation was assessed at 6- and 12-month study visits among all study participants [32].”
Method
Metadata
- Authors
- Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE
- Affiliations
- University of California, San Francisco (US)
- Yale University (US)
- University of California San Diego (US)
- The Ohio State University (US)
- Indiana University Indianapolis (US)
- Johns Hopkins University (US)
- Venue
- AIDS Care
- Publisher
- Informa UK Limited
- Published
- 2000-06
- Volume
- 12
- Issue
- 3
- Pages
- 255-266
- ISSN
- 0954-0121 (ISSN-L)
- 1360-0451
- OpenAlex
- W2088423598
- Cited by
- 1,428
- References
- 12
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 29 · 2023: 29 · 2022: 40 · 2021: 53 · 2020: 51 · 2019: 55 · 2018: 61 · 2017: 66 · 2016: 67 · 2015: 76 · 2014: 81 · 2013: 84 · 2012: 74
- FWCI
- 27.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- AIDS Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (P50-MH42459, P30MH059037, P50MH042459, P30-MH 59037)
- National Institute of Allergy and Infectious Diseases (U01AI-38858, U01AI038858)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- antiretroviral therapy adherence, HIV, self-report questionnaire, medication non-adherence, adherence self-efficacy, alcohol consumption, protease inhibitors, clinical trial participants, questionnaire development
- MeSH terms
- Adult, Alcohol Drinking, Clinical Trials as Topic, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Patient Compliance, Pilot Projects, Surveys and Questionnaires, Risk Factors, Socioeconomic Factors, HIV Infections, Anti-HIV Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review